[1] | Mueser, K.T, Mc Gurk, S.R. Schizophrenia. Lancet 2004; 363: 2063-2072. |
[2] | Williams R, Dickson RA: Economics of schizophrenia. Canadian Journal of Psychiatry 1995; 40:(2)S60-S67. |
[3] | Lacro, J.P., Dunn, L.B., Dolder, C.R., Leckband, S.G., Jeske, D.V. Prevalence of and Risk Factors for Medication non adherence in Patient with Schizophrenia: a Comprehensive Review of Recent Literature. J Clin. Psychiatry.2002;63(10): 892-909. |
[4] | Fenton, W.S., Blyer, C.R., Heinssen, R.K.. Determinants of Medication Compliance in Schizophrenia. Empirical and Clinical Findings. Schizophrenia Bulletin 1997;23: 637-651. |
[5] | Nose M, Bar bui C. and Tansella M. How often do Patients with Psychosis Fail to Adhere to Treatment Programmes? A Systematic Review. Psychol. Med. 2003;33 (7): 1149-1160. |
[6] | Misdrahi D, Llorca PM, Lancon C, Bayle FJ. Compliance in schizophrenia: predictive factors, therapeutic considerations and research implications. Encephale 2002; 28: 266-272 (in French). |
[7] | Haynes R.B, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane data base. Syst Rev. 2008; (2); CD000011. |
[8] | Naber D, Karow A, Lambert M. Subjective well-being under neuroleptic treatment and its relevance to compliance. Acta Psychiatr Scan 2005; 111:232-243. |
[9] | Buchanan A. A two year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992; 22: 787-797 |
[10] | Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry2004; 65:1372-1376. |
[11] | Dixon L, Weiden P, Torres M, Lehman AM. Assertive community treatment and medication compliance in the homeless mentally ill. Am J Psychiatry 1997; 154:1302-1304. |
[12] | Fleischhacker WW, Meise U, Gunther V, Kurz M. Compliance with Anti-psychotic Drug Treatment: Influence of Side Effects. Acta Psychaitric Scand 1994; Suppl 382: 11-15. |
[13] | Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised Controlled trail of Compliance Therapy: 18-month Follow Up. British Journal of Psychiatry. 1998; 1772: 413-419. |
[14] | Hofer A, Kemmler G, Eder U, Honeder M, Hummer M, Fleischhacker WW. Attitude towards antipsychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry 2002; 2002: 49-53 |
[15] | Adelufosi AO, Adebowale TO, Abayomi O, Mosanya JT. Medication adherence and quality of life among Nigerian outpatients with schizophrenia. Gen Hosp Psychiatry 2012;; 34(1): 72-9. |
[16] | World Health Organisation (WHO), ICD 10: International Statistical Classification of Diseases and Related Health Problems, World Health Organisation, Geneva, Switzerland, 10th edition, 1992. |
[17] | www.statpages.org. |
[18] | Adewuya AO, Owoeye OA, Erinfolami AR, Coker AO, Ogun OC, Okewole AO, Dada MU, Eze CN, Bello-Mojeed MA, Akindipe TO, Olagunju AT, Etim E. Prevalence and correlates of poormedication adherence amongst psychiatric patients in South-western Nigeria. Gen. Hosp. Psychiatry 2009; 31(2):167-174. |
[19] | Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatricinterview for DSM-IV and ICD-10, Journal of Clinical Psychiatry 1998;59(20) :22– 33. |
[20] | Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive validity of a Medication adherence measure for hypertension control. J. Clin.Hypertens.2008;10(5):348-354. |
[21] | Kay SR, Fiszbein A, and Opler LA .The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 1987;13(2) 261–276. |
[22] | Hogan TP, Awad AG, Eastwood RA. Self Report Scale Predictive of Drug Compliance in Schizophrenic: Rehabilitative and Discriminative Validity. Psychological Medicine 1983; 13: 177-183. |
[23] | Ibrahim AW, Pindar SK, Yerima MM, Rabbebe IB, Shehu S, Garkuwa HA, Bashir iy, Wakil MA, Yahya SJ. Medication related factors of non adherence among patients with schizophrenia and bipolar disorder: Outcome of cross sectional survey in Maiduguri, North-eastern Nigeria. Journal of Neuroscience and behavioural health 2015; 7(5)31-39. |
[24] | Kane JM. Compliance issues in outpatient treatment. J Clin Psychopharmacol 1985; 5(supp. 3):22S-27S. |
[25] | Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand 1994; 89: 187-190. |
[26] | Amr M, El-Mogy A, El-Masry R (2013). Adherence in Egyptian patients with schizophrenia: the role of insight, medication beliefs and spirituality. Arab J. Psychiatry 2013; 24(1): 60-68. |
[27] | Sackett LD, Haynes RB, Gordon HG, Tugwell P. Clinical Epidemiology. A basic science for clinical medicine. Textbook of Clinical Epedermiology, 2nd edn. London; Little, Brown and Company; 1991. P. 249-277. |
[28] | Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW. Adherance to conventional and atypical antipsychotic after hospital discharge. J Clin Psychiatry 2004; 65(3):354-60. |
[29] | Baby R, S Gupta S, Sagar R. Attitudes and subjective reasons of medication compliance and noncompliance among outpatients with schizophrenia in India. The Internet Journal of Epidemiology. 2008 Volume 7 Number 1. |
[30] | Adewuya AO, Ola BA, Mosaku SK, Fatoye FO, Egunranti AB. Attitude towards antipsychotics among outpatients with schizophrenia in Nigeria. Acta Psychiatr Scand 2006; 113: 207-211. |
[31] | Fenton WS., Blyer CR. Heinssen RK. Determinants of Medication Compliance in Schizophrenia. Empirical and Clinical Findings. Schizophrenia Bulletin 1997; 23: 637-651. |
[32] | Razali MS, Yahya H. Compliance with treatment in schizophrenia: A drug intervention program in a developing program. Acta Psychiatr Scand. 1995; 91: 331-335. |
[33] | Casey, D.E. Barriers to progress-the impact of tolerability problems. Int Clin Psychopharmacol 2001; 16 suppl 1: S15-19. |
[34] | Lacro, J.P., Dunn, L.B., Dolder, C.R., Leckband, S.G., Jeske, D.V. Prevalence of and Risk Factors for Medication non adherence in Patient with Schizophrenia: a Comprehensive Review of Recent Literature. J Clin. Psychiatry. 2002; 63(10): 892-909. |